Development and multi-institutional validation of an artificial intelligence-based diagnostic system for gastric biopsy.
artificial intelligence
deep learning
diagnosis
gastric biopsy
pathology
Journal
Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
10
07
2022
received:
12
04
2022
accepted:
21
07
2022
pubmed:
7
9
2022
medline:
6
10
2022
entrez:
6
9
2022
Statut:
ppublish
Résumé
To overcome the increasing burden on pathologists in diagnosing gastric biopsies, we developed an artificial intelligence-based system for the pathological diagnosis of gastric biopsies (AI-G), which is expected to work well in daily clinical practice in multiple institutes. The multistage semantic segmentation for pathology (MSP) method utilizes the distribution of feature values extracted from patches of whole-slide images (WSI) like pathologists' "low-power view" information of microscopy. The training dataset included WSIs of 4511 gastric biopsy tissues from 984 patients. In tissue-level validation, MSP AI-G showed better accuracy (91.0%) than that of conventional patch-based AI-G (PB AI-G) (89.8%). Importantly, MSP AI-G unanimously achieved higher accuracy rates (0.946 ± 0.023) than PB AI-G (0.861 ± 0.078) in tissue-level analysis, when applied to the cohorts of 10 different institutes (3450 samples of 1772 patients in all institutes, 198-555 samples of 143-206 patients in each institute). MSP AI-G had high diagnostic accuracy and robustness in multi-institutions. When pathologists selectively review specimens in which pathologist's diagnosis and AI prediction are discordant, the requirement of a secondary review process is significantly less compared with reviewing all specimens by another pathologist.
Identifiants
pubmed: 36068652
doi: 10.1111/cas.15514
pmc: PMC9530856
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3608-3617Subventions
Organisme : Japan Agency for Medical Research and Development
ID : JP16lk1010022
Organisme : Japan Agency for Medical Research and Development
ID : JP18lk1010027
Organisme : Japan Agency for Medical Research and Development
ID : JP18lk1010028
Organisme : Japan Agency for Medical Research and Development
ID : JP19lk1010036
Informations de copyright
© 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Références
Gastric Cancer. 2011 Jun;14(2):101-12
pubmed: 21573743
JAMA. 2017 Dec 12;318(22):2199-2210
pubmed: 29234806
Am J Surg Pathol. 2010 May;34(5):609-19
pubmed: 20410811
Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1093-103
pubmed: 10725618
Cancer Sci. 2017 Jan;108(1):101-107
pubmed: 27727490
Arch Pathol Lab Med. 2016 Jan;140(1):29-40
pubmed: 25965939
Gastric Cancer. 2018 Mar;21(2):249-257
pubmed: 28577229
Cell Rep. 2022 Mar 1;38(9):110424
pubmed: 35235802
Am J Med. 2018 Feb;131(2):129-133
pubmed: 29126825
Am J Surg Pathol. 2018 Dec;42(12):1636-1646
pubmed: 30312179
Virchows Arch. 2019 Aug;475(2):131-138
pubmed: 31222375
Cancer Sci. 2022 Oct;113(10):3608-3617
pubmed: 36068652
Int J Cancer. 2013 Aug 1;133(3):653-9
pubmed: 23364866
Sci Rep. 2016 May 23;6:26286
pubmed: 27212078
Gastroenterology. 2017 May;152(6):1319-1328.e7
pubmed: 28147224
World J Gastroenterol. 2016 Jul 28;22(28):6385-92
pubmed: 27605874
Histopathology. 2019 Feb;74(3):372-376
pubmed: 30270453
Nat Commun. 2020 Aug 27;11(1):4294
pubmed: 32855423
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Sci Rep. 2020 Jan 30;10(1):1504
pubmed: 32001752